ZA916313B - New use of a monoclonal antibody - Google Patents

New use of a monoclonal antibody

Info

Publication number
ZA916313B
ZA916313B ZA916313A ZA916313A ZA916313B ZA 916313 B ZA916313 B ZA 916313B ZA 916313 A ZA916313 A ZA 916313A ZA 916313 A ZA916313 A ZA 916313A ZA 916313 B ZA916313 B ZA 916313B
Authority
ZA
South Africa
Prior art keywords
monoclonal antibody
new use
specificity
fragments
variants
Prior art date
Application number
ZA916313A
Other languages
English (en)
Inventor
Hans Loibner
Loibner Hans
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA916313B publication Critical patent/ZA916313B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
ZA916313A 1990-08-11 1991-08-09 New use of a monoclonal antibody ZA916313B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025499A DE4025499A1 (de) 1990-08-11 1990-08-11 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen

Publications (1)

Publication Number Publication Date
ZA916313B true ZA916313B (en) 1993-04-28

Family

ID=6412074

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA916313A ZA916313B (en) 1990-08-11 1991-08-09 New use of a monoclonal antibody

Country Status (13)

Country Link
EP (1) EP0547079B1 (https=)
JP (1) JPH06500771A (https=)
KR (1) KR930701193A (https=)
AT (1) ATE136469T1 (https=)
AU (1) AU657489B2 (https=)
CA (1) CA2088370C (https=)
DE (2) DE4025499A1 (https=)
HU (1) HUT64238A (https=)
IE (1) IE912823A1 (https=)
PT (1) PT98622A (https=)
TW (1) TW223019B (https=)
WO (1) WO1992003165A1 (https=)
ZA (1) ZA916313B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0528767T3 (da) * 1991-08-21 2000-04-17 Novartis Ag antistofderivater
RU2208642C2 (ru) * 1992-05-22 2003-07-20 Новартис Аг МОНОКЛОНАЛЬНОЕ АНТИИДИОТИПИЧЕСКОЕ АНТИТЕЛО Ab2, СПОСОБ ЕГО ПОЛУЧЕНИЯ, ИСПОЛЬЗОВАНИЯ ПРОТИВ БОЛЕЗНЕЙ, СОПРОВОЖДАЮЩИХСЯ ЭКСПРЕССИЕЙ Lewis Y6 АНТИГЕНА, И ДЛЯ ОЧИСТКИ ВАРИАНТА BR55-2 АНТИТЕЛА, ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКИЙ СОСТАВ
ATE249846T1 (de) * 1998-06-29 2003-10-15 Wolfgang Bergter Antivirale und antiretrovirale radioimmunpharmaka auf der basis von alpha- und beta-strahlern

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003206A1 (en) * 1985-11-25 1987-06-04 Quash Gerard A Modified viral glycoproteins, diagnostic and therapeutic uses therefore
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット

Also Published As

Publication number Publication date
IE912823A1 (en) 1992-02-12
WO1992003165A1 (en) 1992-03-05
AU657489B2 (en) 1995-03-16
CA2088370A1 (en) 1992-02-12
JPH06500771A (ja) 1994-01-27
EP0547079A1 (en) 1993-06-23
HU9300349D0 (en) 1993-05-28
HUT64238A (en) 1993-12-28
DE4025499A1 (de) 1992-02-13
TW223019B (https=) 1994-05-01
EP0547079B1 (en) 1996-04-10
DE69118702D1 (de) 1996-05-15
ATE136469T1 (de) 1996-04-15
CA2088370C (en) 2003-03-25
PT98622A (pt) 1992-06-30
AU8393291A (en) 1992-03-17
KR930701193A (ko) 1993-06-11
DE69118702T2 (de) 1996-09-05

Similar Documents

Publication Publication Date Title
FI955315A0 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
FI891716A7 (fi) HIV-proteaasi-inhibiittoreita, jotka ovat käyttökelpoisia AIDS'in hoidossa
IL103981A (en) CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS
DE69109642D1 (de) Anpassungsfähige Formgebung von Verbundwerkstoffen.
ZA93226B (en) Abrasive articles including a crosslinked siloxane, and methods of making and using same.
DE69002805D1 (de) Coextrusionsfaehige klebstoffe und damit hergestellte gegenstaende.
FI906212A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDSin hoidossa
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
AU616156B2 (en) Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
AU7198291A (en) Human monoclonal antibodies against rabies viruses, the production and the use thereof
EP0680093A3 (en) Static induction thyristor and its manufacturing process.
DE68919172D1 (de) MOSFET und dessen Herstellungsverfahren.
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
EP0245993A3 (en) Monoclonal antibodies against c5a and des-arg74-c5a, their production and use
EP0341684A3 (en) Human monoclonal antibody, hybridoma producing the same and pharmaceutical
TR200103432T2 (tr) Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı.
ITVR940096A0 (it) Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
ZA916313B (en) New use of a monoclonal antibody
EP0456727A4 (en) Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof
NO903801L (no) Alkalipullunase, mikroorganisme og fremgangsmaate ved fremstilling derav.
AU657504B2 (en) Antibody against human plasmin-alpha2-plasmin inhibitor complex, hybridoma and immunoassay
PT633928E (pt) Microrganismos processo de preparacao e utilizacao
DK8089A (da) Monoclonale antistoffer, deres fremstilling og anvendelse.
FI960839L (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
NO893818D0 (no) Produksjon og anvendelse av hybride, monoklonale antistoffer.